Pharmaceutical Stocks Rally Across the Board as Kukje Pharm Hits Upper Limit... Shinpoong Pharm and Dongkoo Pharm Also Surge
Strong buying is sweeping across domestic pharmaceutical stocks. In early trading on the 7th, Kukje Pharmaceutical soared to its daily price limit, and the upward momentum is spreading to other pharmaceutical stocks such as Shinpoong Pharmaceutical and Dongkoo Pharmaceutical. ■ Kukje Pharm Hits Upp

Strong buying is sweeping across domestic pharmaceutical stocks. In early trading on the 7th, Kukje Pharmaceutical soared to its daily price limit, and the upward momentum is spreading to other pharmaceutical stocks such as Shinpoong Pharmaceutical and Dongkoo Pharmaceutical.
■ Kukje Pharm Hits Upper Limit in Early Trading... Up 29.91%
As of 9:28 a.m. on the 7th, Kukje Pharmaceutical was trading at 4,430 won, up 1,020 won (29.91%) from the previous session. Buying concentrated immediately after the market open, driving the stock to its upper price limit.
■ Shinpoong Pharm and Dongkoo Pharm Also Surge... Broad Strength in Pharmaceutical Stocks
Kukje Pharmaceutical's strength is spreading warmth to other pharmaceutical stocks. At the same time, Shinpoong Pharmaceutical was trading up 10.13% at 10,650 won, while Dongkoo Pharmaceutical rose 8.76% to 23,600 won.
Daewon Pharmaceutical also climbed 5.58% to 8,320 won, and Kyungnam Pharmaceutical gained 3.91% to 2,125 won. Samsung Pharmaceutical rose 3.53% to 249,500 won, and Myungmoon Pharmaceutical advanced 3.40% to 1,308 won.
In addition, Handok (+2.93%), JW Pharmaceutical (+2.89%), Boryung (+2.70%), and Vivocell (+2.55%) also rose in tandem, with buying flowing into pharmaceutical stocks across the board.
■ Theme-Driven Supply and Demand a Variable... "Cautious Approach Needed"
As Kukje Pharmaceutical hit its upper limit in early trading, attention is focused on how much the related issue will affect the share price movements of pharmaceutical stocks overall. However, as theme-driven supply and demand could amplify short-term price volatility, a cautious approach to investment is advised.
[※ This article is for reference purposes only in making investment decisions; the final judgment and responsibility for investments rest with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Cyberattack via Optimizely Exposes 178 Global Organizations... CNN, BBC, HSBC, and Ledger Also Affected](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F627874%2Ffc472b72a2596aa1%2Fvariants%2Fhero.webp&w=1920&q=75)


